AI-generated summary
The authors pooled 11 randomized controlled trials with 569 obese patients to assess photobiomodulation. They report improvements in waistline, weight, BMI, CRP, total cholesterol and HOMA-IR, but no significant differences for waist-to-hip ratio, fat mass percentage or insulin. They describe the evidence as needing confirmation in larger, longer trials.
- Participants
- 569
- Studies included
- 11
- Who or what was studied
- Obese patients enrolled in randomized controlled trials
- Limits stated in the abstract
- The authors state that further theoretical exploration is needed and that multi-center, large-scale trials with longer follow-up and broader demographics are necessary to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
This meta-analysis is aimed to verify the effectiveness and safety of Photobiomodulation (PBM) on body measurements, metabolic indicators, and inflammation indicators in obese patients across randomized controlled trials with various comparators.
Methods
From the inception of databases to January 5, 2025, we conducted a comprehensive literature search across PubMed, OVID, Cochrane, Embase, Web of Science, LILACS, Chinese Scientific Journals Database (VIP), Wanfang and China National Knowledge Infrastructure (CNKI). Two reviewers independently performed the search, extracted data, and assessed study quality based on predefined inclusion and exclusion criteria. Data analysis was carried out using Review Manager 5.4 software. The reporting and quality assessment of this review study was guided by the PRISMA and AMSTAR.
Results
Eleven RCTs with a total of 569 patients were included in meta-analysis. The pooled data revealed that PBM demonstrated significantly improvements in body anthropometric measurements, such as waistline [MD = - 7.28, 95% CI (- 9.97 to - 5.67), p < 0.00001], weight [MD = - 3.54, 95% CI (- 5.97 to - 1.11), p < 0.00001], BMI [MD = - 1.18, 95% CI (- 1.93 to - 0.43), p = 0.002]. PBM also showed potential in the reduction of CRP [MD = - 0.99, 95% CI (- 1.17 to - 0.82), p < 0.00001], as well as in TC, and HOMA-IR, which is [MD = - 23.01, 95% CI (- 31.68 to - 14.35), p < 0.00001] and [MD = - 0.46, 95% CI (- 0.73 to - 0.20), p = 0.0007] respectively. No significant differences were found in reducing WHR [MD = - 0.05, 95% CI (- 0.1 to 0.00), p = 0.05], fat mass percentage [MD = - 0.28, 95% CI (- 1.25 to 0.69), p = 0.57] and insulin [MD = - 1.98, 95% CI (- 4.20 to 0.23), p = 0.08].
Conclusion
The results of our study suggest that PBM may offer potential benefits for treating obesity, showing some improvements in key indicators such as BMI, weight, waist circumference, CRP, TC, and HOMA-IR compared to exercise, dietary changes, and sham PBM. However, further theoretical exploration of PBM is needed, and multi-center, large-scale trials with longer follow-up durations and demographic range are necessary to confirm and validate the findings of our study.
Registration Number
CRD42024532988.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Meta-analysis, Photobiomodulation therapy, Systematic review, Inflammation, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.